Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Alibaba (9988 HK): 3Q23 and more

In today’s briefing:

  • Alibaba (9988 HK): 3Q23, Growth Flat, But Margin Up, Buy
  • Perfect Medical: Calm Start to the Year, Correction Provides Good Entry Point
  • Baidu: Undervalued Cyclical Revenue Growth Acceleration and Margin Expansion Story
  • Taiwan Semiconductors Mid-Earnings Season Review: Margins, Inventories Appear Worse Than Expected
  • Aeon Retail: Profits Again After 4 Years
  • Automaker GAC Seeks China-Made Chips to Ease Dependence on Foreign Suppliers
  • AI Leaders Monitor: Nvidia, TSMC, ASML Trading Monitor – Nvidia Results Key Take-Aways
  • Kubota (6326) | Signs of Stability
  • Apollo Hospitals Enterprise (APHS IN): Q3 Profit Drops; Hospital Business Remains the Brightest Spot
  • New U.S. CHIPS Act Speech: Commerce Secretary Emphasizes National Security Game Changer; Conclusions

Alibaba (9988 HK): 3Q23, Growth Flat, But Margin Up, Buy

By Ming Lu

  • Revenue grew by 2% YoY in 3Q22, as the decrease of online sales offset the increase of physical stores.
  • The operating margin began to improve, as the company cut sales and marketing expenses in minor businesses.
  • We believe the stock has an upside of 78% for March 2024 and the price target will be HK$170.

Perfect Medical: Calm Start to the Year, Correction Provides Good Entry Point

By Sameer Taneja

  • A correction in Perfect Medical Health’s (1830 HK) share price recently has led to it trading at a decent multiple of 15.2x/11.6x FY23e/24e PE(x) with a 6.9%/9.1% FY23e/24e dividend yield. 
  • We estimate the lockdowns in China from Oct-Dec last year will impact the H2 FY23 result, leading to softer revenue growth of 4.8% for FY23 (profit 11% YoY). 
  • We are optimistic about China re-opening and cross-border travel and believe that >20% revenue growth can materialize in FY24, led by a recovery in China/HK revenue. 

Baidu: Undervalued Cyclical Revenue Growth Acceleration and Margin Expansion Story

By Wium Malan, CFA

  • Following several years of sustained revenue share loss, Search’s digital advertising revenue market share has stabilised, having seemingly retained its core advertising customers.
  • With China’s economic growth recovery, Baidu is perfectly positioned to accelerate its core marketing revenue growth, which is also a high-margin operation.
  • Baidu is set up for significant group margin expansion as the higher-margin core marketing business returns to positive annualised growth and it continues to expand AI Cloud margins.

Taiwan Semiconductors Mid-Earnings Season Review: Margins, Inventories Appear Worse Than Expected

By Vincent Fernando, CFA

  • We’re now two-thirds through the Taiwan Semiconductor earnings season and about one-third through the Taiwan Hardware earnings season.
  • Semiconductor gross margins declines have been relatively large, and we believe are tracking to be worse than what consensus expected going into the earnings season.
  • There have been few examples of inventory situations improving for semicondcutor companies; results data released so far indicates a potentially deeper trough than previously expected.

Aeon Retail: Profits Again After 4 Years

By Michael Causton

  • Aeon’s main GMS arm, Aeon Retail, is on track to post a net profit in FY2023 after a 4-fold increase in OP in 1H2022.
  • This is largely thanks to stronger sales and footfall and the success of efficiency measures introduced over the past few years.
  • The improvements look sustainable and should lead to improved results for Aeon longer-term adding to the already good results from the drugstore, real estate and overseas businesses.

Automaker GAC Seeks China-Made Chips to Ease Dependence on Foreign Suppliers

By Caixin Global

  • Guangzhou Automobile Group Co. Ltd. (GAC) (601238.SH -0.51%) is working to get more domestically produced microchips into its vehicles.
  • It relies on overseas suppliers for about 90% of its automotive chips.
  • GAC Capital Co. Ltd. sees plenty of opportunity to increase the share of domestic chips in the automaker’s cars.

AI Leaders Monitor: Nvidia, TSMC, ASML Trading Monitor – Nvidia Results Key Take-Aways

By Vincent Fernando, CFA

  • The three companies Nvidia, TSMC, and ASML are all key global leaders in the AI industry chain.
  • Nvidia’s latest results indicate that the company could be returning to a period of multi-year growth and an inflection point for AI demand.
  • One can consider going Long a basket of Nvidia, ASML, and TSMC based on a structural growth thesis for AI demand.

Kubota (6326) | Signs of Stability

By Mark Chadwick

  • We turn bullish on Kubota. Macro indicators point to stabilization 
  • Management guidance for 2023 surprised the market, but we think it is realistic
  • We think that quarterly results will be a catalyst to convince investors that profitability is improving

Apollo Hospitals Enterprise (APHS IN): Q3 Profit Drops; Hospital Business Remains the Brightest Spot

By Tina Banerjee

  • Apollo Hospitals Enterprise (APHS IN) recorded 19% revenue growth in Q3. The largest segment, healthcare services, which contributed 51% of total revenue, grew 10%. However, net profit dropped 33%.
  • The company’s bottom line bled mainly due to high operating cost of the digital healthcare services platform, Apollo 24/7. Excluding operating cost of Apollo 24/7 EBITDA would have grown 10%.
  • The company believes that it is at the peak burn rate for Apollo 24/7 operating cost this quarter and expects losses to moderate from here on.

New U.S. CHIPS Act Speech: Commerce Secretary Emphasizes National Security Game Changer; Conclusions

By Vincent Fernando, CFA

  • U.S. Commerce Secretary gave a new speech providing additional public detail about the U.S. CHIPS Act aimed at re-shoring the manufacture of semiconductors in the U.S.
  • Emphasis on national security means that financial cost is now secondary for the U.S. and we should not expect any loosening of chip restrictions for China.
  • Taiwan companies are straddling a “sweet spot” given they are not restricted, can invest in the U.S. expansion, maintain local non-U.S. advantages, and have had their China-based competition weakened.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars